{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:07:23Z","timestamp":1774958843722,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1053\/j.ajkd.2012.11.043","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T05:37:18Z","timestamp":1359005838000},"page":"579-587","source":"Crossref","is-referenced-by-count":97,"title":["Efficacy and Safety of Sitagliptin in Patients With Type 2 Diabetes and ESRD Receiving Dialysis: A 54-Week Randomized Trial"],"prefix":"10.1053","volume":"61","clinical-trial-number":[{"clinical-trial-number":"nct00509236","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Juan C.","family":"Arjona Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalila","family":"Corry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl E.","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory T.","family":"Golm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith D.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry J.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2012.11.043_bib1","first-page":"e1","article-title":"USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","volume":"59","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2012.11.043_bib2","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/ndt\/gfq199","article-title":"Strict glycaemic control in diabetic patients with CKD or ESRD: beneficial or deadly?","volume":"25","author":"Schernthaner","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2012.11.043_bib3","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1053\/j.ajkd.2006.12.005","article-title":"KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease","volume":"49","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2012.11.043_bib4","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-Jarvinen","year":"2004","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2012.11.043_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1185\/030079908X261069","article-title":"Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials","volume":"24","author":"Karasik","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1053\/j.ajkd.2012.11.043_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6823-10-7","article-title":"Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes","volume":"10","author":"Williams-Herman","year":"2010","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"10.1053\/j.ajkd.2012.11.043_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.clpt.2005.09.002","article-title":"Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses","volume":"78","author":"Herman","year":"2005","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1053\/j.ajkd.2012.11.043_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clinthera.2006.01.015","article-title":"Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers","volume":"28","author":"Bergman","year":"2006","journal-title":"Clin Ther"},{"issue":"7","key":"10.1053\/j.ajkd.2012.11.043_bib9","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2337\/dc06-2545","article-title":"Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor","volume":"30","author":"Bergman","year":"2007","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1053\/j.ajkd.2012.11.043_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1463-1326.2008.00914.x","article-title":"Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency","volume":"10","author":"Chan","year":"2008","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1053\/j.ajkd.2012.11.043_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/sim.4780040211","article-title":"Comparative analysis of two rates","volume":"4","author":"Miettinen","year":"1985","journal-title":"Stat Med"},{"issue":"11","key":"10.1053\/j.ajkd.2012.11.043_bib12","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1210\/jc.2006-1009","article-title":"Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes","volume":"91","author":"Herman","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1053\/j.ajkd.2012.11.043_bib13","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.2337\/dc06-0703","article-title":"Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes","volume":"29","author":"Aschner","year":"2006","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1053\/j.ajkd.2012.11.043_bib14","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1007\/s00125-006-0416-z","article-title":"Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus","volume":"49","author":"Raz","year":"2006","journal-title":"Diabetologia"},{"key":"10.1053\/j.ajkd.2012.11.043_bib15","doi-asserted-by":"crossref","unstructured":"Arjona-Ferreira JC, Marre M, Barzilai N, et al. Efficacy and safety of sitagliptin vs. glipizide in patients with type 2 diabetes and moderate to severe chronic renal insufficiency [published online ahead of print December 17, 2012]. Diabetes Care. doi:10.2337\/dc12-1365.","DOI":"10.2337\/dc12-1365"},{"issue":"2","key":"10.1053\/j.ajkd.2012.11.043_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1463-1326.2006.00704.x","article-title":"Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial","volume":"9","author":"Nauck","year":"2007","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1053\/j.ajkd.2012.11.043_bib17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.287.3.360","article-title":"Oral antihyperglycemic therapy for type 2 diabetes: scientific review","volume":"287","author":"Inzucchi","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.ajkd.2012.11.043_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1463-1326.2009.01187.x","article-title":"Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes","volume":"12","author":"Aschner","year":"2010","journal-title":"Diabetes Obes Metab"},{"issue":"9548","key":"10.1053\/j.ajkd.2012.11.043_bib19","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.1053\/j.ajkd.2013.07.007","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000}}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612015107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612015107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T03:20:31Z","timestamp":1539919231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638612015107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0272638612015107"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2012.11.043","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717976613.793470820","asserted-by":"object"}]},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}